P Pörsti

A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.

M.H. Frick, P Halttunen, P. Himanen et al. · British Journal of Clinical Pharmacology · 1986 · 68 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension

M.H. Frick, David A. Cox, P. Himanen et al. · The American Journal of Cardiology · 1987 · 68 citations

Pharmacy, Pharmacology, Pharmacotherapy +11

Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.

Matthias Frick, P Pörsti · BMJ · 1976 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol.

Frick Mh, M Hartikainen, P Pörsti · PubMed · 1978 · 13 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of the Converting Enzyme Inhibitor Quinapril (CI-906) on Blood Pressure, Renin-Angiotensin System, and Prostanoids in Essential Hypertension

P Säynävälammi, Ilkka Pörsti, P Pörsti et al. · Journal of Cardiovascular Pharmacology · 1988 · 12 citations

Pharmacy, Pharmacology, Pharmacotherapy +15